Closing Price ($) | Shares Out (MM) | Market Cap ($MM) |
$0.00 | 0 | $0 |
20-F | 2017-12-31 | Annual: 2017-12-31 |
20-F | 2016-12-31 | Annual: 2016-12-31 |
20-F | 2015-12-31 | Annual: 2015-12-31 |
Comps ($MM TTM) | Market Cap | Assets | Liabilities | Revenue | Gross Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|
Apollo Education (APOL) | 1,063 | 1,955 | 886 | 2,000 | 0 | -20 | 98 | 579 |
China Crawfish (CACA) | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
Mirenco (MREO) | ||||||||
Weyland Tech (WEYL) | 11 | 5 | 29 | -1 | -4 | -4 | -5 | |
Lingo Media (LMDC) | 1 | 1 | 0 | 0 | 0 | 0 | -0 | |
Granite Real Estate (GRP) | ||||||||
Wewin Group (WWIN) | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
MWF Global (MWF) | 0 | 0 | -0 | -0 | -0 | |||
Frontier Digital Media Group (FDMG) | 0 | 0 | 0 | 0 | -0 | -0 | -0 | |
Brighthouse Life Insurance Co of Ny (BHNY) | 9,066 | 8,030 | 237 | 0 | 0 | 3 | -190 | |
G-Mes Holdings (GMES) | 1 | 1 | 1 | 1 | 0 | 0 | -0 | |
Baynon (BNON) | 0 | 0 | 0 | 0 | -0 | -0 | 0 | |
Immune Therapeutics (IMUN) | 0 | 0 | 13 | 0 | 0 | -5 | -5 | -0 |
Green Planet Bio Engineering (GPLB) | 3 | 0 | 0 | 0 | 0 | -0 | -0 | 3 |
Blue Sphere (BLSP) | 1 | 44 | 87 | 8 | 3 | -14 | -14 | 9 |
Therapeutic Solutions (TSOI) | 0 | 0 | 2 | 0 | 0 | -2 | -1 | 0 |
Stem Holdings (STEMH) | 41 | 6 | 1 | 0 | -8 | -7 | -5 | |
SpringWorks (SWTX) | ||||||||
Clean Coal Technologies (CCTC) | 0 | 17 | 0 | 0 | -6 | -3 | 1 | |
Ryanair Holdings (RYAA) | 13,251 | 8,036 | 0 | 0 | 0 | 0 | -35 |
Balance Sheet ($MM) | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 |
Cash | 1,977 | 676 | 1,249 | 987 | 200 | 390 | 183 |
Accounts Receivable | 538 | 957 | 745 | 1,068 | 364 | 321 | 338 |
Inventory | 684 | 839 | 752 | 849 | 406 | 338 | 294 |
PP&E | 4,716 | 4,780 | 4,483 | 4,587 | 877 | 756 | 838 |
Assets | 10,401 | 9,151 | 8,862 | 9,398 | 2,548 | 2,209 | 2,263 |
Accounts Payable | 1,025 | 1,062 | 696 | 767 | 226 | 171 | 180 |
Long-Term Debt | |||||||
Liabilities | 6,097 | 6,404 | 6,972 | 8,022 | 2,207 | 1,801 | 1,807 |
Stockholders' Equity | 2,747 | 1,890 | 1,376 | 340 | 408 | 456 | |
Income Statement ($MM) | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 |
Revenue | |||||||
Cost of Revenue | |||||||
Gross Profit | |||||||
R&D | |||||||
SG&A | |||||||
Tax | |||||||
Net Income | |||||||
Cash Flow ($MM) | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 |
Cash Operating | |||||||
Cash Investing | |||||||
Cash Financing |